Yukiko Kiniwa
YOU?
Author Swipe
View article: Effectiveness and Prognosis of Systemic Chemotherapy for Unresectable Malignant Apocrine and Eccrine Tumors: A Real-World Multicenter Retrospective Study
Effectiveness and Prognosis of Systemic Chemotherapy for Unresectable Malignant Apocrine and Eccrine Tumors: A Real-World Multicenter Retrospective Study Open
PURPOSE Malignant apocrine and eccrine tumors (MAETs) are extremely rare cutaneous adnexal malignancies, accounting for only 0.005%-0.01% of all skin tumors. These tumors are highly metastatic, and evidence regarding optimal chemotherapy a…
View article: Author Correction: Immune evasion through mitochondrial transfer in the tumour microenvironment
Author Correction: Immune evasion through mitochondrial transfer in the tumour microenvironment Open
View article: Prognosis of a deep excision margin within or beyond subcutaneous fat for invasive acral melanoma of the sole: A multi-institutional retrospective study
Prognosis of a deep excision margin within or beyond subcutaneous fat for invasive acral melanoma of the sole: A multi-institutional retrospective study Open
Wide local excision beyond the subcutaneous fat was not associated with survival benefit of acral melanoma of the sole. Excision within the subcutaneous fat may represent the optimal deep margin.
View article: Immune checkpoint inhibitor-associated myocarditis: a novel risk score
Immune checkpoint inhibitor-associated myocarditis: a novel risk score Open
Background and Aims Immune checkpoint inhibitors (ICI) are associated with life-threatening myocarditis but milder presentations are increasingly recognized. The same autoimmune process that causes ICI myocarditis can manifest concurrent g…
View article: Comparing 2 cm vs. 1 cm surgical margins in acral melanoma of the sole with Breslow thickness greater than 2 mm: A multicenter retrospective study of 336 Japanese patients
Comparing 2 cm vs. 1 cm surgical margins in acral melanoma of the sole with Breslow thickness greater than 2 mm: A multicenter retrospective study of 336 Japanese patients Open
View article: Japanese Dermatological Association Guidelines: Clinical Questions of Guidelines for Melanoma 2025
Japanese Dermatological Association Guidelines: Clinical Questions of Guidelines for Melanoma 2025 Open
Advancements in melanoma management have underscored the need for periodic guideline updates every few years to reflect current clinical practices. Previous versions of melanoma clinical practice guidelines in Japan have primarily aimed to…
View article: Adjuvant Anti–PD-1 Monotherapy Versus Observation for Stage III Acral Melanoma of the Sole: A Multicenter Retrospective Study in Japanese Patients
Adjuvant Anti–PD-1 Monotherapy Versus Observation for Stage III Acral Melanoma of the Sole: A Multicenter Retrospective Study in Japanese Patients Open
PURPOSE Adjuvant anti–PD-1 (adj PD-1) antibodies are extensively used to improve survival in patients with resected melanoma. Clinical trials on adj PD-1 antibodies have revealed significant improvements in recurrence-free survival (RFS); …
View article: Publisher Correction: Immune evasion through mitochondrial transfer in the tumour microenvironment
Publisher Correction: Immune evasion through mitochondrial transfer in the tumour microenvironment Open
View article: Pulmonary metastases from malignant melanoma showing ground-glass opacity nodules
Pulmonary metastases from malignant melanoma showing ground-glass opacity nodules Open
View article: Immune evasion through mitochondrial transfer in the tumour microenvironment
Immune evasion through mitochondrial transfer in the tumour microenvironment Open
View article: Effectiveness and Prognosis of Systemic Chemotherapy for Unresectable Malignant Apocrine and Eccrine Tumors: A Real-World, Retrospective, Multi-Center Study
Effectiveness and Prognosis of Systemic Chemotherapy for Unresectable Malignant Apocrine and Eccrine Tumors: A Real-World, Retrospective, Multi-Center Study Open
View article: A case of chronic lymphocytic leukemia/small lymphocytic lymphoma diagnosed by skin lesions
A case of chronic lymphocytic leukemia/small lymphocytic lymphoma diagnosed by skin lesions Open
View article: An Excerpt Highlighting Differences Between Japanese and Western Melanoma Clinical Guidelines
An Excerpt Highlighting Differences Between Japanese and Western Melanoma Clinical Guidelines Open
View article: The efficacy and safety of pazopanib as a second-line treatment for patients with paclitaxel-pretreated primary cutaneous angiosarcoma – results of JCOG1605 study
The efficacy and safety of pazopanib as a second-line treatment for patients with paclitaxel-pretreated primary cutaneous angiosarcoma – results of JCOG1605 study Open
View article: Genetic Characteristics of Cutaneous, Acral, and Mucosal Melanoma in Japan
Genetic Characteristics of Cutaneous, Acral, and Mucosal Melanoma in Japan Open
Background Acral and mucosal melanomas are more prevalent in Asians than in Caucasians, unlike cutaneous melanomas, which are predominant in Caucasians. Recent studies have suggested that non‐Caucasian cutaneous melanomas responded less to…
View article: Supplementary Table S6 from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling
Supplementary Table S6 from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling Open
Differentially expressed genes between the exhausted CD8+ T cells and the others
View article: Figure S3 from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling
Figure S3 from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling Open
Multiplexed fluorescent immunohistochemistry
View article: Figure S4 from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling
Figure S4 from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling Open
Additional CD106 expression data in PBMCs
View article: TableS3 from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling
TableS3 from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling Open
Summary of the antibodies used in flow cytometry analyses
View article: Figure S3 from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling
Figure S3 from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling Open
Multiplexed fluorescent immunohistochemistry
View article: TableS2 from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling
TableS2 from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling Open
Patient characteristics for prognostic analyses
View article: Data from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling
Data from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling Open
T-cell exhaustion is a major contributor to immunosuppression in the tumor microenvironment (TME). Blockade of key regulators of T-cell exhaustion, such as programmed death 1, can reinvigorate tumor-specific T cells and activate antitumor …
View article: Figure S6 from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling
Figure S6 from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling Open
Influence of CD106 on various surface molecules
View article: Figure S1 from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling
Figure S1 from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling Open
Additional scRNA-seq data
View article: Supplementary Table S6 from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling
Supplementary Table S6 from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling Open
Differentially expressed genes between the exhausted CD8+ T cells and the others
View article: Figure S5 from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling
Figure S5 from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling Open
Additional CD106 functional analysis data
View article: TableS1 from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling
TableS1 from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling Open
Patient characteristics for scRNA/TCR-seq or flow cytometry
View article: TableS2 from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling
TableS2 from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling Open
Patient characteristics for prognostic analyses
View article: Figure S4 from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling
Figure S4 from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling Open
Additional CD106 expression data in PBMCs
View article: Figure S1 from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling
Figure S1 from CD106 in Tumor-Specific Exhausted CD8<sup>+</sup> T Cells Mediates Immunosuppression by Inhibiting TCR Signaling Open
Additional scRNA-seq data